A Study to Investigate Tonlamarsen for the Treatment of Adults With Uncontrolled Hypertension (KARDINAL)

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 206 participants.

Also called NCT06864104

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 206 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT06864104
Other papers using this trial's data
  • Efficacy of Tonlamarsen in Patients With Uncontrolled Hypertension: The KARDINAL Phase 2 Randomized Clinical Trial Journal of the American College of Cardiology, 2026-05-12 DOI, PubMed 41949512

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT06864104. Randomized; quadruple masking; primary purpose treatment. Start 2025-04-10 (actual); primary completion 2026-01-12 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Study to Investigate Tonlamarsen for the Treatment of Adults With Uncontrolled Hypertension (KARDINAL)
Condition
Hypertension
Intervention (Drug)
Tonlamarsen
Intervention (Drug)
Placebo
Lead sponsor
Kardigan, Inc. (class: industry)

Record details

Record id
cardio:ct-nct06864104
Content hash
52eb9d60eeb99e95aa386883644ea046ee31ee21e0818cc8c4e3615276606eb7